Company intelligence / Profile preview
Venenum Biodesign
Hamilton, New Jersey, United Statesvenenumbiodesign.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Venenum Biodesign has demonstrated success in identifying multiple novel chemotypes using its ECLiPS platform. Lead compounds have been optimized and advanced into in vivo studies but there are no published clinical results or ongoing human trials as of now.
- Therapeutic areas
- OncologyMetabolic DisordersInfectious DiseasesImmunologyWomen's Health
- Modalities
- Small moleculeRecombinant proteinProtein engineering/productionsiRNA technologyPeptides
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Venenum Biodesign.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Venenum Biodesign.